BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26256743)

  • 1. [Side effects of anticancer treatment and the needs for translational research on toxicity: a clinician's perspective].
    Shimizu C
    Nihon Yakurigaku Zasshi; 2015 Aug; 146(2):72-5. PubMed ID: 26256743
    [No Abstract]   [Full Text] [Related]  

  • 2. Learning from exceptional drug responders.
    Mullard A
    Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
    Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
    Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational science.
    Venkatakrishnan K; Ecsedy JA
    Clin Pharmacol Ther; 2017 Jan; 101(1):99-113. PubMed ID: 27804123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational research to realize the full potential of novel agents--an opportunity for vinflunine?
    Yip AY; Ong EY; Chow LW
    Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S5-8. PubMed ID: 21957991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing transformative clinical trials in the cancer genome era.
    Sleijfer S; Bogaerts J; Siu LL
    J Clin Oncol; 2013 May; 31(15):1834-41. PubMed ID: 23589555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational research in the National Cancer Institute's cooperative groups.
    Symmans WF
    Clin Adv Hematol Oncol; 2014 Nov; 12(11):785-7. PubMed ID: 25674720
    [No Abstract]   [Full Text] [Related]  

  • 8. New microtubule-inhibiting anticancer agents.
    Chen SM; Meng LH; Ding J
    Expert Opin Investig Drugs; 2010 Mar; 19(3):329-43. PubMed ID: 20141350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal drug formulations in cancer therapy: 15 years along the road.
    Slingerland M; Guchelaar HJ; Gelderblom H
    Drug Discov Today; 2012 Feb; 17(3-4):160-6. PubMed ID: 21983329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New anticancer drugs: much ado about nothing?].
    Zimmermann S; Betticher D
    Rev Med Suisse; 2014 Apr; 10(425):788, 790-3. PubMed ID: 24791424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 12. Translational research in phase I trials.
    Fasolo A; Sessa C
    Clin Transl Oncol; 2009 Sep; 11(9):580-8. PubMed ID: 19775997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer research. Can fasting blunt chemotherapy's debilitating side effects?
    Couzin J
    Science; 2008 Aug; 321(5893):1146-7. PubMed ID: 18755948
    [No Abstract]   [Full Text] [Related]  

  • 14. [Translational medicine].
    Antal J; Timár A
    Orv Hetil; 2011 Nov; 152(47):1894-902. PubMed ID: 22042316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 16. Precision oncology: an overview.
    Garraway LA; Verweij J; Ballman KV
    J Clin Oncol; 2013 May; 31(15):1803-5. PubMed ID: 23589545
    [No Abstract]   [Full Text] [Related]  

  • 17. Translational and clinical studies of target-based cancer therapy.
    Saijo N; Nishio K; Tamura T
    Int J Clin Oncol; 2003 Aug; 8(4):187-92. PubMed ID: 12955572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
    Perry WL; Weitzman A
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):199-202, 237-8. PubMed ID: 16166991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular target therapeutics of cancer and translational research].
    Shiotsu Y
    Nihon Yakurigaku Zasshi; 2011 Jun; 137(6):241-4. PubMed ID: 21666343
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral delivery of anticancer drugs I: general considerations.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):25-34. PubMed ID: 22951365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.